Work

Prevalence and influencing factors of thyroid dysfunction and glucose metabolism disorders in transfusion-dependent beta-thalassemia patients in Guangxi

Year: 2026
Type: article
Study design: Observational Study
Abstract: Endocrinopathies, particularly thyroid dysfunction and glucose metabolism disorders (GMD), are common in transfusion-dependent β-thalassemia (TDT) patients, but data from Guangxi remain limited. We assessed the prevalence of thyroid dysfunction and GMD and explored associations with anemia and iron metabolism. This cross-sectional study included 440 TDT patients; hematological, iron, thyroid, and glucose indices were measured. Logistic regression was used to identify associated factors. Among 440 patients, 0.2% had hypothyroidism and 22.3% had subclinical hypothyroidism. Among 165 patients assessed for GMD, 5.5% had diabetes mellitus, 2.4% had impaired fasting glucose, and 20.0% had impaired glucose tolerance; 7.9% had both thyroid dysfunction and GMD. Hematocrit was independently associated with thyroid dysfunction (OR 0.93, 95%CI 0.88–0.98). In the 165 glucose-tested patients, red blood cell count (RBC; OR 0.46, 95%CI 0.25–0.87), transferrin (OR 1.21, 95%CI 1.03–1.42), serum ferritin ≥ 2500 ng/mL (OR 3.59, 95%CI 1.28–10.02), and body mass index (BMI; OR 1.33, 95%CI 1.11–1.60) were associated with GMD. Thyroid dysfunction and GMD were prevalent and often coexisted. Hematocrit, RBC, and transferrin may be correlates of these complications. Given the cross-sectional design, these associations should be interpreted cautiously and require prospective validation; nevertheless, monitoring anemia- and iron-related indices may help identify TDT patients requiring further endocrine assessment.
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $4,590
OpenAlex ID: W7236680152
FWCI:
Cites:
Cited by:
Related to: 10